Cargando…
Robust home brew fragment sizing assay for detection of MET exon 14 skipping mutation in non–small cell lung cancer patients in resource constrained community hospitals
BACKGROUND: A mutation/deletion involving donor or acceptor sites for exon 14 results in splicing out of exon 14 of the mesenchymal epithelial transition (MET) gene and is known as “MET exon 14 skipping” (ΔMET14). The two recent approvals with substantial objective responses and improved progression...
Autores principales: | Mehta, Anurag, Nathany, Shrinidhi, Chopra, Aanchal, Mattoo, Sakshi, Kumar, Dushyant, Panigrahi, Manoj Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476318/ https://www.ncbi.nlm.nih.gov/pubmed/34465078 http://dx.doi.org/10.4132/jptm.2021.07.15 |
Ejemplares similares
-
Unusual Resistance Mechanisms in a Case of ROS1-Rearranged NSCLC: A Case Report
por: Batra, Ullas, et al.
Publicado: (2022) -
KRAS mutated Non‐Small Lung Carcinoma: A Real World Context from the Indian subcontinent
por: Batra, Ullas, et al.
Publicado: (2022) -
Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management
por: Veillon, Remi, et al.
Publicado: (2022) -
ExonSkipDB: functional annotation of exon skipping event in human
por: Kim, Pora, et al.
Publicado: (2020) -
Exon skipping for DMD
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2012)